E-LIB Suche - Ergebnisse für: Peter End

1

Novel Bruton's tyrosine kinase inhibitor remibrutinib: Asse..:

Schiller, Hilmar ; Huth, Felix ; Schuhler, Carole...
European Journal of Pharmaceutical Sciences. 172 (2022) - p. 106155 , 2022

Link: https://doi.org/10.1016/..

2

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:

Huth, Felix ; Schiller, Hilmar ; Jin, Yi...
Clinical and Translational Science. 15 (2021) 1 - p. 118-129 , 2021

Link: https://doi.org/10.1111/..

3

Remibrutinib (LOU064): A selective potent oral BTK inhibito..:

Kaul, Martin ; End, Peter ; Cabanski, Maciej...
Clinical and Translational Science. 14 (2021) 5 - p. 1756-1768 , 2021

Link: https://doi.org/10.1111/..

4

MO042LNP023: A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FA..:

Junge, Guido ; Holbro, Thomas ; End, Peter...
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

5

New Perspectives on Drug-Induced Liver Injury Risk Assessme..:

Walles, Markus ; Brown, Alan P. ; Zimmerlin, Alfred.
Chemical Research in Toxicology. 33 (2020) 7 - p. 1551-1560 , 2020

Link: https://doi.org/10.1021/..

6

Fevipiprant has a low risk of influencing co-medication pha..:

Poller, Birk ; Woessner, Ralph ; Barve, Avantika...
Pulmonary Pharmacology & Therapeutics. 57 (2019) - p. 101809 , 2019

Link: https://doi.org/10.1016/..

7

High-Throughput Melanin-Binding Affinity and In Silico Meth..:

Reilly, John ; Williams, Sarah L. ; Forster, Cornelia J....
Journal of Pharmaceutical Sciences. 104 (2015) 12 - p. 3997-4001 , 2015

Link: https://doi.org/10.1002/..

8

Discovery of BAF312 (Siponimod), a Potent and Selective S1P..:

Pan, Shifeng ; Gray, Nathanael S. ; Gao, Wenqi...
ACS Medicinal Chemistry Letters. 4 (2013) 3 - p. 333-337 , 2013

Link: https://doi.org/10.1021/..

9

Urinary clusterin, cystatin C, β2-microglobulin and total p..:

Dieterle, Frank ; Perentes, Elias ; Cordier, André...
Nature Biotechnology. 28 (2010) 5 - p. 463-469 , 2010

Link: https://doi.org/10.1038/..

10

Domains of laminin with growth-factor activity:

Panayotou, George ; End, Peter ; Aumailley, Monique..
Cell. 56 (1989) 1 - p. 93-101 , 1989

Link: https://doi.org/10.1016/..

11

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:

Felix Huth ; Hilmar Schiller ; Yi Jin...
https://doi.org/10.1111/cts.13126. , 2022

Link: https://doi.org/10.1111/..

12

Remibrutinib (LOU064): A selective potent oral BTK inhibito..:

Martin Kaul ; Peter End ; Maciej Cabanski...
https://doi.org/10.1111/cts.13005. , 2021

Link: https://doi.org/10.1111/..

13

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:

Huth, Felix ; Schiller, Hilmar ; Jin, Yi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742645/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Remibrutinib (LOU064): A selective potent oral BTK inhibito..:

Kaul, Martin ; End, Peter ; Cabanski, Maciej...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504815/. , 2021

Link: http://www.ncbi.nlm.nih...

15

A Unidirectional 96-Well Fluidic Culture Platform for Upstr..:

John, Bincy A ; Sloan, David J ; Jensen, Timothy C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743950/. , 2021

Link: http://www.ncbi.nlm.nih...